Nutritional Management of Hyperkalemic Infants With Chronic Kidney Disease, Using Adult Renal Formulas

被引:9
作者
Hobbs, David J.
Gast, Tracy R.
Ferguson, Karen B.
Bunchman, Timothy E. [1 ]
Barletta, Gina-Marie
机构
[1] Helen DeVos Childrens Hosp, Dept Pediat Nephrol Dialysis & Transplantat, Grand Rapids, MI 49503 USA
关键词
SODIUM POLYSTYRENE SULFONATE; YOUNG-CHILDREN; FAILURE; DIALYSIS; GROWTH; REDUCE;
D O I
10.1053/j.jrn.2009.06.003
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Objective: This study sought to evaluate the use of adult renal formulas in hyperkalemic infants with chronic kidney disease (CKD). Design: This was a retrospective, single-center cohort study. Setting: This study took place at the Department of Pediatric Nephrology, Dialysis, and Transplantation at Helen DeVos Children's Hospital (Grand Rapids, MI). Patients: Seven hyperkalemic infants (mean age, 6.9 months) comprised the study population: 29% with stage 3 CKD, 29% with stage 4 CKD, and 42% with stage 5 CKD. Intervention: Infants were empirically treated with adult renal formulas for an average duration of 9.6 months. Six of seven infants were started on breast milk or infant formula (Similac PM 60/40, Abbott Laboratories, Columbus, OH), but because of inadequate growth and hyperkalemia, were transitioned to adult renal formulas (Suplena, Abbott Laboratories, Columbus, OH; Nepro, Abbott Laboratories, Columbus, OH; and/or Renalcal, Nestle Nutrition, Minnetonka, MN). One infant received adult renal formula at birth. Main Outcome Measures: The outcome measures included amount of potassium delivered by infant and adult renal formulas, level of serum potassium, and anthropometric measurements adjusted for age and gender (z-scores). Results: The transition from infant to adult renal formula resulted in a decrease in mean amount of potassium delivered by formula (from 2.6 to 1.0 mEq/kg/day, P < .001) and a decrease in mean serum potassium (from 5.1 to 4.0 mmol/L, P < .01). During treatment with adult renal formula, the infants demonstrated a significant increase in mean weight z-score (from -1.0 to 0.5, P < .01), height z-score (from -1.9 to -0.5, P<.01), and head-circumference z-score (from -1.5 to -1.0, P = .03). Adult renal formulas were well-tolerated. Conclusions: Hyperkalemic infants with CKD can be nutritionally managed on adult renal formula. (C) 2010 by the National Kidney Foundation, Inc. All rights reserved
引用
收藏
页码:121 / 126
页数:6
相关论文
共 13 条
[1]   CHRONIC DIALYSIS IN THE INFANT LESS-THAN 1 YEAR OF AGE [J].
BUNCHMAN, TE .
PEDIATRIC NEPHROLOGY, 1995, 9 :S18-S22
[2]   PRETREATMENT OF FORMULA WITH SODIUM POLYSTYRENE SULFONATE TO REDUCE DIETARY POTASSIUM INTAKE [J].
BUNCHMAN, TE ;
WOOD, EG ;
SCHENCK, MH ;
WEAVER, KA ;
KLEIN, BL ;
LYNCH, RE .
PEDIATRIC NEPHROLOGY, 1991, 5 (01) :29-32
[3]   Outcomes of dialysis initiated during the neonatal period for treatment of end-stage renal disease: A North American Pediatric Renal Trials and Collaborative Studies special analysis [J].
Carey, William A. ;
Talley, Lynya I. ;
Sehring, Sally A. ;
Jaskula, Janet M. ;
Mathias, Robert S. .
PEDIATRICS, 2007, 119 (02) :E468-E473
[4]  
Fassinger N, 1998, ADV PERIT D, V14, P274
[5]   Outcome and growth of infants with severe chronic renal failure [J].
Kari, JA ;
Gonzalez, C ;
Ledermann, SE ;
Shaw, V ;
Rees, L .
KIDNEY INTERNATIONAL, 2000, 57 (04) :1681-1687
[6]   Long-term enteral nutrition in infants and young children with chronic renal failure [J].
Ledermann, SE ;
Shaw, V ;
Trompeter, RS .
PEDIATRIC NEPHROLOGY, 1999, 13 (09) :870-875
[7]  
Parekh RS, 2001, J AM SOC NEPHROL, V12, P2418, DOI 10.1681/ASN.V12112418
[8]  
Reed E E, 1998, J Ren Nutr, V8, P122, DOI 10.1016/S1051-2276(98)90002-4
[9]   Sodium polystyrene sulfonate used to reduce the potassium content of a high-protein enteral formula: A quantitative analysis [J].
Rivard, AL ;
Raup, SM ;
Beilman, GJ .
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2004, 28 (02) :76-78
[10]   MANAGEMENT OF HYPERKALEMIA WITH A CATION-EXCHANGE RESIN [J].
SCHEER, L ;
RUBIN, AL ;
SPRITZ, N ;
MEAD, AW ;
OGDEN, DA .
NEW ENGLAND JOURNAL OF MEDICINE, 1961, 264 (03) :115-+